ADMA Biologics, Inc. ADMA
13.15 USD -0.19 (-1.42%)
As ofNov 20, 2026, 2:53 PM EST
13.13 Day range 13.29
7.21 52-week range 20.46
- YTD
- -27.91%
- 1 year
- -19.62%
Held by funds
157 US ETFs and mutual funds hold ADMA · largest positions
- IJR 0.17% of fund $178.75M
- FBT 4.10% of fund $128.05M
- NIR 0.11% of fund $114.42M
- IWM 0.10% of fund $78.73M
- VTI 0.00% of fund $65.39M
- XBI 0.59% of fund $63.16M
- NJM 0.05% of fund $42.29M
- IWO 0.20% of fund $28.64M
- SPSM 0.17% of fund $27.28M
- IJT 0.35% of fund $26.68M
- VXF 0.03% of fund $25.37M
- VB 0.01% of fund $24.03M
- FSSNX 0.07% of fund $23.72M
- IBB 0.19% of fund $21.84M
- DFAS 0.06% of fund $19.60M
- SLYG 0.35% of fund $16.78M
- NLT 0.22% of fund $16.48M
- SCHA 0.07% of fund $15.79M
- NLO 0.10% of fund $14.75M
- VTWO 0.08% of fund $13.45M
Ownership
- Institutions 92.9%
- Insiders 1.97%
- Public and other holders 5.10%
Held by insiders 1.97%
Held by institutions 92.93%
Float held by institutions 94.79%
Institutions 450
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.82% | 37,305,140 | 497.28M | Sep 29, 2026 |
| State Street Corporation | 6.16% | 13,675,348 | 182.29M | Sep 29, 2026 |
| Rubric Capital Management LP | 5.57% | 12,352,584 | 164.66M | Sep 29, 2026 |
| First Trust Advisors LP | 4.53% | 10,041,022 | 133.85M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.27% | 9,468,196 | 126.21M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 4.15% | 9,207,177 | 122.73M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 6.01% | 13,332,053 | 177.72M | Sep 29, 2026 |
| First TRT Exch-Trd Fd.-First TRT NYSE Arca Biotechnology Index Fd. | 4.49% | 9,970,973 | 132.91M | Sep 29, 2026 |
| SmallCap World Fund Inc | 3.84% | 8,524,390 | 113.63M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 7,023,200 | 93.62M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.69% | 5,963,003 | 79.49M | Sep 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.04% | 4,534,131 | 60.44M | Sep 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ELMS STEVEN A | Director | Purchase | Mar 5, 2026 | 0 |
| FINGER ALISON CECILY | Director | Stock Award(Grant) | Feb 8, 2026 | 45,619 |
| GROSSMAN ADAM S | Chief Executive Officer | Conversion of Exercise of derivative security | Nov 15, 2026 | 3,789,160 |
| GROSSMAN JERROLD B | Director | Purchase | May 26, 2026 | 612,991 |
| GUIHEEN LAWRENCE P | Director | Conversion of Exercise of derivative security | Nov 15, 2026 | 186,510 |
| KESTENBERG-MESSINA KAITLIN M. | Officer | Conversion of Exercise of derivative security | Mar 8, 2026 | 466,600 |
